Forschungsschwerpunkte

 

Lehrstuhl für Molekulare Pathobiochemie, Experimentelle Gentherapie und Klinische Chemie

- Functional analysis of PDGF and TGF-beta signaling in hepatic fibrogenesis
- Development of novel therapeutic strategies for the treatment of liver fibrosis
- Characterisation of novel animal models for the study of organ fibrosis
- Transcriptional targeting of hepatic stellate cells
- Functional and structural analysis of LIM domain proteins (e.g. CRP2)
- Development of novel, gene-based tests for analysis fibrosis progression and predisposition
- Adenoviral expression technology
- Establishment of novel diagnostic parameters